Neuronetics, Inc.

Informe acción NasdaqGM:STIM

Capitalización de mercado: US$100.5m

Neuronetics Dirección

Dirección controles de criterios 2/4

El CEO de Neuronetics es Keith Sullivan , nombrado en Jul 2020, tiene una permanencia de 5.67 años. compensación anual total es $2.43M, compuesta por 30% salario y 70% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.7% de las acciones de la empresa, por valor de $1.70M. La antigüedad media del equipo directivo y de la junta directiva es de 1.2 años y 4.9 años, respectivamente.

Información clave

Keith Sullivan

Chief Executive Officer (CEO)

US$2.4m

Compensación total

Porcentaje del salario del CEO29.95%
Permanencia del CEO5.7yrs
Participación del CEO1.7%
Permanencia media de la dirección1.2yrs
Promedio de permanencia en la Junta Directiva4.9yrs

Actualizaciones recientes de la dirección

Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All

May 15
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

Recent updates

Clinic Network And New Therapies Will Transform Mental Health Treatment Over The Next Decade

Catalysts About Neuronetics Neuronetics develops and commercializes NeuroStar TMS systems and operates Greenbrook clinics that provide device based and drug treatments for mental health conditions, including treatment resistant depression. What are the underlying business or industry changes driving this perspective?

There's No Escaping Neuronetics, Inc.'s (NASDAQ:STIM) Muted Revenues Despite A 25% Share Price Rise

Jan 07
There's No Escaping Neuronetics, Inc.'s (NASDAQ:STIM) Muted Revenues Despite A 25% Share Price Rise

Would Neuronetics (NASDAQ:STIM) Be Better Off With Less Debt?

Dec 13
Would Neuronetics (NASDAQ:STIM) Be Better Off With Less Debt?

Slammed 29% Neuronetics, Inc. (NASDAQ:STIM) Screens Well Here But There Might Be A Catch

Nov 14
Slammed 29% Neuronetics, Inc. (NASDAQ:STIM) Screens Well Here But There Might Be A Catch

The Neuronetics, Inc. (NASDAQ:STIM) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 06
The Neuronetics, Inc. (NASDAQ:STIM) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 29% Lower

Aug 26
Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 29% Lower

Here's What Analysts Are Forecasting For Neuronetics, Inc. (NASDAQ:STIM) After Its Second-Quarter Results

Aug 07
Here's What Analysts Are Forecasting For Neuronetics, Inc. (NASDAQ:STIM) After Its Second-Quarter Results

Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All

May 15
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All

Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets

May 09
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets

Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors

May 04
Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors
User avatar

TMS Acquisition And BMP Expansion Will Transform Treatment Delivery

The acquisition of Greenbrook and expansion of the BMP program are expected to significantly boost revenue through increased patient access and operational efficiency.

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Mar 30

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story

Mar 06
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story

Industry Analysts Just Made A Dazzling Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) Revenue Forecasts

Feb 10
Industry Analysts Just Made A Dazzling Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) Revenue Forecasts

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 43% Yet They're Still Not Telling The Full Story

Jan 11
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 43% Yet They're Still Not Telling The Full Story

Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt

Jan 02
Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt

Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12%

Nov 18
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12%

A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb

Nov 05
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb

Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Aug 13
Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding

Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

May 24
Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet

The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 09
The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Neuronetics: Reality Set In

May 09

Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

May 08
Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower

Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

May 01
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Mar 17
Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely

Neuronetics: Modest Improvements Are Not Enough

Jan 30

Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Dec 19
Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Jun 21
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story

Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

May 10
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Keith Sullivan en comparación con los beneficios de Neuronetics?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2025n/an/a

-US$39m

Sep 30 2025n/an/a

-US$45m

Jun 30 2025n/an/a

-US$49m

Mar 31 2025n/an/a

-US$49m

Dec 31 2024US$2mUS$728k

-US$44m

Sep 30 2024n/an/a

-US$36m

Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$3mUS$700k

-US$30m

Sep 30 2023n/an/a

-US$33m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$37m

Dec 31 2022US$2mUS$676k

-US$37m

Sep 30 2022n/an/a

-US$37m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$3mUS$650k

-US$31m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$23m

Dec 31 2020US$4mUS$280k

-US$27m

Compensación vs. Mercado: La compensación total de Keith($USD2.43M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD610.84K).

Compensación vs. Ingresos: La compensación de Keith ha sido consistente con los resultados de la empresa en el último año.

CEO

Keith Sullivan (67 yo)

5.7yrs
Permanencia
US$2,430,610
Compensación

Mr. Keith J. Sullivan has been President, Chief Executive Officer and Director of Neuronetics, Inc. since July 14, 2020. Mr. Sullivan has been a Director of Venus Concept Inc. (formerly known as Restoratio...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Keith Sullivan
President5.7yrsUS$2.43m1.7%
$ 1.7m
W. Macan
EVP, Chief Legal Officer & Corporate Secretary6.2yrsUS$1.06m1.27%
$ 1.3m
Stephen Furlong
Senior Advisor to the CEOless than a yearUS$1.18m0.21%
$ 206.7k
Steven Pfanstiel
Executive VPless than a yearsin datossin datos
Jeffrey Jones
Senior VP & Chief of Operations1.2yrssin datossin datos
Cory Anderson
SVP & Chief Technology Officer1.2yrssin datossin datos
Lisa Metzner-Rosas
Senior VP & Chief Marketing Officer2.8yrssin datossin datos
1.2yrs
Permanencia media
61yo
Promedio de edad

Equipo directivo experimentado: El equipo directivo de STIM no se considera experimentado ( 1.2 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Keith Sullivan
President5.7yrsUS$2.43m1.7%
$ 1.7m
Glenn Muir
Independent Director8.7yrsUS$132.92k0.49%
$ 495.6k
Sheryl Conley
Independent Director6.4yrsUS$128.33k0.28%
$ 278.0k
Robert Cascella
Independent Chairman of the Board4.9yrsUS$255.21k0.80%
$ 801.1k
Avinash Amin
Independent Director1.3yrsUS$14.25k0.018%
$ 18.1k
Sasha Cucuz
Independent Director1.3yrsUS$17.57k2.14%
$ 2.2m
Megan Rosengarten
Independent Director4.6yrsUS$121.67k0.12%
$ 124.5k
4.9yrs
Permanencia media
64yo
Promedio de edad

Junta con experiencia: La junta directiva de STIM se considera experimentada (4.9 años de antigüedad promedio).

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/03/23 16:04
Precio de las acciones al final del día2026/03/20 00:00
Beneficios2025/12/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo usar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Neuronetics, Inc. está cubierta por 3 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
William PlovanicCanaccord Genuity
Daniel StauderCitizens JMP Securities, LLC
Adam MaederPiper Sandler Companies